B.C. Centre for Excellence in HIV/AIDS

Laboratory

The primary goal of the basic research program is to expand existing B.C. HIV/AIDS Drug Treatment Program database with novel virological and drug information for HIV-infected British Columbians receiving antiretroviral therapy.

Key priorities include:

Understanding and preventing drug resistance.
The development, application and evaluation of innovative cost-effective laboratory tests that monitor HIV therapy response and antiretroviral drug toxicities.
Improving drug adherence through the development and application of laboratory-based tools that accurately detect and report non-adherence.
Investigation of the relationships between human and viral genetic factors and treatment outcomes.
Therapeutic drug monitoring.

The research laboratory team includes individuals with expertise in virology, genomics, chemistry, molecular biology and quality assurance systems.


Home Home Visitor Information Contact us About us Introduction Our mandate Milestones Directors Clinical John Ruedy Immunodeficiency Clinic B.C. HIV/AIDS Drug Treatment Program Therapeutic guidelines Antiretroviral Outreach Program Laboratory Introduction Services Guidelines Research Clinical Population health Studies/projects Laboratory Published Papers CfE Conference Abstracts 2005 2004 2003 2002 2001 2000 1999 Resources and Conferences Education Introduction Video presentations Partnerships Vancouver Coastal Health Authority Prime Trials The Canadian HIV Trials Network University of British Columbia Oak Tree Clinic International News Media releases Forecast Webmail Live Broadcast
	PRINT Research Laboratory The primary goal of the basic research program is to expand existing B.C. HIV/AIDS Drug Treatment Program database with novel virological and drug information for HIV-infected British Columbians receiving antiretroviral therapy. Key priorities include: Understanding and preventing drug resistance. The development, application and evaluation of innovative cost-effective laboratory tests that monitor HIV therapy response and antiretroviral drug toxicities. Improving drug adherence through the development and application of laboratory-based tools that accurately detect and report non-adherence. Investigation of the relationships between human and viral genetic factors and treatment outcomes. Therapeutic drug monitoring. The research laboratory team includes individuals with expertise in virology, genomics, chemistry, molecular biology and quality assurance systems.